MCID: EST001
MIFTS: 20

Estrogen-Receptor Positive Breast Cancer malady

Cancer diseases category

Aliases & Classifications for Estrogen-Receptor Positive Breast Cancer

About this section

Estrogen-Receptor Positive Breast Cancer, Aliases & Descriptions:

Name: Estrogen-Receptor Positive Breast Cancer 9 11


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases


External Ids:

Disease Ontology9 DOID:0060075

Summaries for Estrogen-Receptor Positive Breast Cancer

About this section


MalaCards based summary: Estrogen-Receptor Positive Breast Cancer is related to breast cancer and estrogen-receptor negative breast cancer. An important gene associated with Estrogen-Receptor Positive Breast Cancer is GPR152 (G protein-coupled receptor 152). Affiliated tissues include breast, lymph node and bone.

Related Diseases for Estrogen-Receptor Positive Breast Cancer

About this section

Diseases in the Estrogen-Receptor Negative Breast Cancer family:

estrogen-receptor positive breast cancer

Diseases related to Estrogen-Receptor Positive Breast Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

idRelated DiseaseScoreTop Affiliating Genes
1breast cancer11.6
2estrogen-receptor negative breast cancer10.6
3endotheliitis10.5
4obesity10.4
5parametritis10.4
6fallopian tube cancer10.4
7thyroiditis10.4
8blindness10.4
9resistance to tamoxifene10.4

Graphical network of diseases related to Estrogen-Receptor Positive Breast Cancer:



Diseases related to estrogen-receptor positive breast cancer

Symptoms for Estrogen-Receptor Positive Breast Cancer

About this section

Drugs & Therapeutics for Estrogen-Receptor Positive Breast Cancer

About this section

Drug clinical trials:

Search ClinicalTrials for Estrogen-Receptor Positive Breast Cancer

Search NIH Clinical Center for Estrogen-Receptor Positive Breast Cancer

Genetic Tests for Estrogen-Receptor Positive Breast Cancer

About this section

Anatomical Context for Estrogen-Receptor Positive Breast Cancer

About this section

MalaCards organs/tissues related to Estrogen-Receptor Positive Breast Cancer:

31
Breast, Lymph node, Bone, Testes, Endothelial, Thyroid, T cells, Neutrophil

Animal Models for Estrogen-Receptor Positive Breast Cancer or affiliated genes

About this section

Publications for Estrogen-Receptor Positive Breast Cancer

About this section

Articles related to Estrogen-Receptor Positive Breast Cancer:

(show top 50)    (show all 277)
idTitleAuthorsYear
1
Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer. (25878567)
2015
2
Association of miR-1266 with recurrence/metastasis potential in estrogen receptor positive breast cancer patients. (25640367)
2015
3
Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer. (24793340)
2014
4
Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer. (24826798)
2014
5
Breast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer. (25075270)
2014
6
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. (25212826)
2014
7
Optimal management of the premenopausal patient with estrogen receptor-positive breast cancer. (24857090)
2014
8
Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer. (25431237)
2014
9
Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect. (25369051)
2014
10
The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence. (23717438)
2013
11
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. (23845444)
2013
12
Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer. (23844228)
2013
13
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. (24213953)
2013
14
Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer. (23902164)
2013
15
Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen. (23459444)
2013
16
Treatment of estrogen receptor-positive breast cancer. (23278394)
2013
17
Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy. (23587451)
2013
18
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. (23205744)
2013
19
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients. (23280127)
2012
20
Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer. (22404099)
2012
21
Mouse models of estrogen receptor-positive breast cancer. (22279420)
2011
22
Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells. (22216287)
2011
23
Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX. (22811953)
2011
24
Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer Cells. (23467843)
2011
25
Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. (21119029)
2011
26
Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. (22021667)
2011
27
Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer. (21731516)
2011
28
PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. (21613801)
2011
29
Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments. (21533195)
2011
30
Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginning. (21447809)
2011
31
Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR]. (20677155)
2010
32
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. (19844788)
2010
33
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. (20065188)
2010
34
The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. (20086172)
2010
35
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic? (20346095)
2010
36
MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer. (20380160)
2010
37
Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer. (20195744)
2010
38
Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer. (19619298)
2009
39
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. (19118060)
2009
40
Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells. (18827493)
2008
41
Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. (17317819)
2007
42
Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer. (17634531)
2007
43
Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related. (16735717)
2006
44
High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer. (15254706)
2004
45
Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. (12444551)
2002
46
A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. (11474128)
2001
47
Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. (9632722)
1998
48
Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. (8558219)
1996
49
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed? (7707102)
1995
50
Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. (7079745)
1982

Variations for Estrogen-Receptor Positive Breast Cancer

About this section

Expression for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section
Search GEO for disease gene expression data for Estrogen-Receptor Positive Breast Cancer.

Pathways for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section

Compounds for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section

GO Terms for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section

Products for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Estrogen-Receptor Positive Breast Cancer

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet